Development of a decision support system for diagnosis and grading of brain tumours using in vivo magnetic resonance single voxel spectra.
Fulltext:
50008.pdf
Embargo:
until further notice
Size:
1.355Mb
Format:
PDF
Description:
Publisher’s version
Publication year
2006Author(s)
Source
NMR in Biomedicine, 19, 4, (2006), pp. 411-34ISSN
Publication type
Article / Letter to editor
Display more detailsDisplay less details
Organization
Radiology
Pathology
Journal title
NMR in Biomedicine
Volume
vol. 19
Issue
iss. 4
Page start
p. 411
Page end
p. 34
Subject
CTR 1: Functional imaging; IGMD 1: Functional imaging; IGMD 5: Health aging / healthy living; IGMD 8: Mitochondrial medicine; NCMLS 3: Tissue engineering and pathology; NCMLS 4: Energy and redox metabolism; ONCOL 3: Translational research; ONCOL 5: Aetiology, screening and detection; UMCN 1.1: Functional ImagingAbstract
A computer-based decision support system to assist radiologists in diagnosing and grading brain tumours has been developed by the multi-centre INTERPRET project. Spectra from a database of 1H single-voxel spectra of different types of brain tumours, acquired in vivo from 334 patients at four different centres, are clustered according to their pathology, using automated pattern recognition techniques and the results are presented as a two-dimensional scatterplot using an intuitive graphical user interface (GUI). Formal quality control procedures were performed to standardize the performance of the instruments and check each spectrum, and teams of expert neuroradiologists, neurosurgeons, neurologists and neuropathologists clinically validated each case. The prototype decision support system (DSS) successfully classified 89% of the cases in an independent test set of 91 cases of the most frequent tumour types (meningiomas, low-grade gliomas and high-grade malignant tumours--glioblastomas and metastases). It also helps to resolve diagnostic difficulty in borderline cases. When the prototype was tested by radiologists and other clinicians it was favourably received. Results of the preliminary clinical analysis of the added value of using the DSS for brain tumour diagnosis with MRS showed a small but significant improvement over MRI used alone. In the comparison of individual pathologies, PNETs were significantly better diagnosed with the DSS than with MRI alone.
This item appears in the following Collection(s)
- Academic publications [244262]
- Electronic publications [131202]
- Faculty of Medical Sciences [92892]
Upload full text
Use your RU credentials (u/z-number and password) to log in with SURFconext to upload a file for processing by the repository team.